4.7 Article

Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus

Journal

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jamda.2016.07.007

Keywords

Frailty; sarcopenia; diabetes mellitus; FRAIL; SARC-F

Funding

  1. Medical Student Training in Aging Research Grant - American Federation of Aging Research

Ask authors/readers for more resources

Objectives: Diabetes mellitus is associated with premature aging, and chronic diabetes is associated with significant physical and cognitive complications. We aimed to examine frailty and sarcopenia rates and 6-month health outcomes in a clinic-based sample of patients with diabetes. Design: This study was an observational study. Participants were recruited from June 2014 to August 2014, and follow-up was conducted 6 months after day of screening. Setting: Participants were recruited at outpatient endocrinology, geriatric, and internal medicine clinics affiliated with Saint Louis University in St. Louis, Missouri. Participants: Participants were persons with diabetes mellitus ages 50 to 90. Measurements: Frailty and sarcopenia were identified using the FRAIL and SARC-F screens, respectively. A chart review of the patient's health record was performed on day of screening and at follow-up. A 6-month phone questionnaire was performed to evaluate health outcomes. Logistic regressions were used to evaluate health outcomes. Results: A total of 198 persons with diabetes were recruited. Of the sample, 32.3% of the sample was nonfrail, 38.9% was prefrail, and 28.8% was frail; 29.3% of the sample was identified to have sarcopenia. Prefrail [odds ratio (OR) 2.92, 95% confidence interval (CI) 1.15-7.42; P=.025] and frail (OR 4.70, 95% CI 1.67-13.19; P=.003) participants were more likely to be hospitalized overnight at 6-month follow-up. Frail (OR 3.57 95% CI 1.27-10.04; P=.016) participants were more likely to have a new activities of daily living (ADL) disability at follow-up; this association was not present for prefrail participants (OR 1.30, 95% CI .50-3.37; P=.59). Participants with sarcopenia were more likely to be hospitalized (OR 3.80, 95% CI 1.67-8.61; P=.001) and to have a new ADL disability (OR 4.24, 95% CI 1.76-10.18; P=.001) at 6-month follow-up. Conclusions: Among clinic patients with diabetes mellitus ages 50-90 years old, frailty and sarcopenia prevalence is high, and both syndromes are predictors of being hospitalized overnight and new ADL disability after 6 months. (C) 2016 of AMDA - The Society for Post-Acute and Long-Term Care Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available